USD 909.2 million
Sacral Nerve Stimulation (SNS) Market Size, Share, Growth Analysis, By Type(Implantable Pulse Generators (IPGs), and Leads), By Application(Urinary Incontinence, Fecal Incontinence, and Chronic Pain), By End-user(Hospitals, Ambulatory Surgical Centers (ASCs), and Specialty Clinics), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35J2066 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
89
|Figures:
76
Sacral Nerve Stimulation (SNS) Market Insights
Sacral Nerve Stimulation (SNS) Market size was valued at USD 909.70 million in 2022 and is poised to grow from USD 1037.69 million in 2023 to USD 2974.68 million by 2031, growing at a CAGR of 14.07% during the forecast period (2024-2031)
The global Sacral Nerve Stimulation (SNS) market is experiencing robust growth due to various factors, including the increasing prevalence of urge incontinence, such as Urinary Tract Infection (UTI), and a rising number of patients suffering from Overactive Bladder (OAB) and fecal incontinence. SNS involves the implantation of a device that delivers controlled electrical impulses to the sacral nerves, which regulate neural pathways and control bladder functions. This treatment is considered safe and effective for patients experiencing urinary and fecal dysfunction, particularly those who have not achieved satisfactory results from therapy and medication. The Center for Medicare and Medicaid Services (CMS) reports that approximately 13 million adults in the United States, predominantly women, are affected by urinary incontinence. SNS has proven to significantly enhance the quality of life for these individuals. Moreover, the incidence of fecal incontinence is also on the rise, contributing to the growth of the SNS market. Fecal incontinence is a debilitating condition that not only affects an individual's quality of life but can also lead to social isolation. Research conducted by the international neuromodulation society reveals a high prevalence of fecal incontinence among the geriatric population in the United Kingdom. This condition is primarily influenced by factors related to the lower gastrointestinal tract and nervous system, such as stool volume, mental function, consistency, colonic and rectal function, as well as sphincter control. The increasing number of patients suffering from fecal incontinence will therefore drive the demand for SNS devices.
US Sacral Nerve Stimulation (SNS) Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Implantable Pulse Generators (IPGs)
Fastest Growth
Implantable Pulse Generators (IPGs)
Growth Rate
14.07% CAGR
Global Sacral Nerve Stimulation (SNS) Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Sacral Nerve Stimulation (SNS) Market Segmental Analysis
The Global Sacral Nerve Stimulation (SNS) Market is segmented by type, application, end-user, and region. Based on type, the market can be segmented into implantable pulse generators (IPGs), and leads. Based on application, the market is segmented into urinary incontinence, fecal incontinence, and chronic pain. Based on end-user, the market is segmented into hospitals, ambulatory surgical centers (ascs), and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Sacral Nerve Stimulation (SNS) Market Analysis by Type
By type, the market can be segmented into implantable pulse generators (IPGs), and leads. Implantable Pulse Generators (IPGs) are the dominating segment in the Sacral Nerve Stimulation Market. IPGs are devices that are implanted in the body to deliver electrical impulses to the sacral nerves. They play a crucial role in providing therapeutic benefits for conditions such as urinary incontinence, fecal incontinence, and chronic pain. Ongoing advancements in IPGs, such as improved battery life, miniaturization, and enhanced programming capabilities, have further strengthened their position in the market. These advancements attract healthcare providers and patients, fostering the dominance of this segment.
The Leads segment is the fastest growing segment in the Sacral Nerve Stimulation Market. Leads refer to the thin wires connected to the IPGs, which are placed near the sacral nerves to transmit electrical impulses. Leads offer flexibility in terms of electrode placement and programming options. This customization allows healthcare providers to tailor the therapy according to the specific needs of patients, leading to increased adoption and market growth.
Sacral Nerve Stimulation (SNS) Market Analysis by Application
By application, the market is segmented into urinary incontinence, fecal incontinence, and chronic pain. Urinary incontinence is the dominating segment in the Sacral Nerve Stimulation Market. It refers to the involuntary leakage of urine, which can significantly impact a person's quality of life. Sacral Nerve Stimulation has emerged as a successful treatment option for managing urinary incontinence. Urinary incontinence affects a substantial population, particularly among the elderly and women. The growing prevalence of this condition creates a significant demand for effective treatment options, positioning urinary incontinence as the dominating segment.
The Chronic Pain segment is identified as the fastest growing segment in the Sacral Nerve Stimulation Market. Chronic pain refers to persistent or recurrent pain lasting for an extended period, typically three months or longer. Sacral Nerve Stimulation has shown promise as a therapeutic option for managing certain chronic pain conditions. Chronic pain conditions can be challenging to treat, and traditional pain management approaches may not always provide satisfactory relief. Sacral Nerve Stimulation offers a non-pharmacological alternative, attracting attention from healthcare professionals and patients seeking innovative solutions. This drives the rapid growth of the chronic pain segment.
Global Sacral Nerve Stimulation (SNS) Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Sacral Nerve Stimulation (SNS) Market Regional Insights
North America emerges as the dominating region in the global Sacral Nerve Stimulation (SNS) market. The region's dominance can be attributed to several factors. Firstly, the high prevalence of urinary incontinence and fecal incontinence cases in the region has created a significant demand for SNS devices. According to the Center for Medicare and Medicaid Services (CMS), around 13 million adults, mostly women, in the United States alone are affected by urinary incontinence. This substantial patient population drives the adoption of SNS devices in the region.
Asia Pacific is the fastest growing region in the global Sacral Nerve Stimulation market. The region's rapid growth can be attributed to several factors. Firstly, the increasing awareness about advanced treatment options for urinary and fecal dysfunction among healthcare professionals and patients is driving the demand for SNS devices. As healthcare infrastructure improves and access to specialized healthcare services expands in countries like China and India, the adoption of SNS devices is expected to rise significantly.
Global Sacral Nerve Stimulation (SNS) Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Sacral Nerve Stimulation (SNS) Market Dynamics
Sacral Nerve Stimulation (SNS) Market Drivers
Increasing cases of urge incontinence
- Increasing cases of urge incontinence, such as Urinary Tract Infection (UTI), and rising number of patients suffering from Overactive Bladder (OAB) and fecal incontinence are driving the growth of the global Sacral Nerve Stimulation (SNS) market. SNS, as a treatment option, offers a safe and effective solution for patients who have not achieved satisfactory results from therapy and medication. With the prevalence of urinary and fecal dysfunction on the rise, particularly among the geriatric population, there is a growing demand for SNS devices. This driver is fueled by the need to improve the quality of life for affected individuals, enhance bladder functions, and mitigate the impact of these conditions on daily activities.
Sacral Nerve Stimulation (SNS) Market Restraints
High cost associated with SNS devices and procedures
- One significant restraint in the global Sacral Nerve Stimulation (SNS) market is the high cost associated with SNS devices and procedures. The expenses involved in implanting and maintaining SNS devices can be a barrier to adoption for some patients and healthcare systems. The cost of the device itself, along with surgical procedures, follow-up appointments, and potential complications, can create financial burdens. Additionally, reimbursement policies and limitations imposed by healthcare payers can further limit the accessibility of SNS treatment. The high cost of SNS devices and related expenses may hinder widespread adoption and limit market growth, particularly in regions with limited healthcare resources or financial constraints.
Request Free Customization of this report to help us to meet your business objectives.
Sacral Nerve Stimulation (SNS) Market Competitive Landscape
The global Sacral Nerve Stimulation (SNS) market showcases a mix of established manufacturers, emerging players, and technological innovators. Companies in the market are actively engaged in research and development activities to enhance the efficacy and safety of SNS devices. They are also focused on expanding their product portfolios to cater to the evolving needs of patients and healthcare professionals. Collaborations, partnerships, and strategic acquisitions are common strategies employed by companies to strengthen their market position. Additionally, market players are investing in marketing and promotional activities to raise awareness about SNS treatment options and to capture a larger market share.
Sacral Nerve Stimulation (SNS) Market Top Player’s Company Profiles
- Nevro Corporation (US)
- StimGuard (US)
- Nuvectra Corporation (US)
- Cyberonics (US)
- IntraPace (US)
- NeuroPace, Inc. (US)
- Synapse Biomedical Inc. (US)
- ReShape Lifesciences (US)
- MicroTransponder (US)
- EnteroMedics (US)
- Inspire Medical Systems (US)
- Second Sight Medical Products (US)
- Saluda Medical (US)
- CVRx (US)
- Laboratory Corporation of America Holdings (US)
- Cogentix Medical (US)
- BlueWind Medical (UK)
Sacral Nerve Stimulation (SNS) Market Recent Developments
- In June 2023, Nuvectra Corporation announced a strategic partnership with a global medical device company to enhance the development and commercialization of its sacral nerve stimulation system.
- In April 2023, Boston Scientific received FDA approval for its WaveWriter Alpha SCS System, a spinal cord stimulation device that incorporates sacral nerve stimulation capabilities for chronic pain management.
- In March 2023, Medtronic and Axonics settled a patent infringement lawsuit related to sacral nerve stimulation technologies, enabling both companies to focus on advancing their respective offerings.
- In January 2023, BlueWind Medical announced the completion of a $40 million financing round to support the commercialization of its sacral nerve stimulation platform for various indications.
- In September 2022, Micro Systems Technologies and EndoStim entered into a collaboration to develop miniaturized implantable components for sacral nerve stimulation systems used in gastroesophageal reflux disease (GERD) treatment.
Sacral Nerve Stimulation (SNS) Key Market Trends
- Increasing focus on miniaturization and wireless technology: One key market trend in the Sacral Nerve Stimulation (SNS) industry is the increasing focus on miniaturization and wireless technology in SNS devices. Manufacturers are striving to develop smaller, more compact devices that offer enhanced patient comfort and convenience. This trend is driven by the growing demand for minimally invasive procedures and the desire to reduce the physical burden on patients. Miniaturized SNS devices allow for easier implantation and potentially fewer post-operative complications. Moreover, the integration of wireless technology enables improved patient monitoring, data collection, and remote programming, facilitating personalized treatment and reducing the need for frequent clinic visits.
Sacral Nerve Stimulation (SNS) Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to global sacral nerve stimulation (SNS) market analysis, the market looks promising, with opportunities for growth and innovation. The market is expected to expand further due to the increasing prevalence of urinary and fecal dysfunction, along with the rising demand for effective treatment options. Dominating regions such as North America, particularly the United States, are currently leading the market due to advanced healthcare infrastructure, a high prevalence of incontinence cases, and the presence of key market players. On the other hand, the Asia Pacific region, with countries like China and India, is witnessing the fastest growth, driven by increasing awareness, an aging population, and economic development. As for countries, the United States holds the largest market share, while China stands as the fastest-growing country in terms of market growth. These factors indicate a positive outlook for the SNS market, offering potential opportunities for market players and improved quality of life for patients suffering from urinary and fecal dysfunction.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 909.70 million |
| Market size value in 2031 | USD 2974.68 million |
| Growth Rate | 14.07% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Sacral Nerve Stimulation (SNS) Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Sacral Nerve Stimulation (SNS) Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Sacral Nerve Stimulation (SNS) Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Sacral Nerve Stimulation (SNS) Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Sacral Nerve Stimulation (SNS) Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Sacral Nerve Stimulation (SNS) Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
